Gil Beyen is the Chairman and CEO of ERYTECH Pharma, a biopharmaceutical company focused on tumor starvation therapies and cancer treatments.
Gil Beyen is the Chairman and CEO of ERYTECH Pharma, a biopharmaceutical company focused on tumor starvation therapies and cancer treatments. He has led the company through clinical trials in Europe and the U.S., including Phase 1 to Phase 3 studies.
Full founder directory · Investor directory · Company funding database · Fundraising library